Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ottesen

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Urology|May 1, 1992
Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failureT C Gerstenberg, P Metz, B Ottesen, et al.
Clinical and Experimental Pharmacology & Physiology|January 1, 1990
Vasoactive intestinal polypeptide and human vaginal blood flow: comparison between transvaginal and intravenous administrationC Palle, H E Bredkjaer, B Ottesen, et al.
American Journal of Obstetrics and Gynecology|February 1, 1991
Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopauseC Palle, H E Bredkjaer, J Fahrenkrug, et al.
Endocrinology|October 1, 1984
Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyisB Ottesen, B Hansen, J Fahrenkrug, et al.
Brain Research|March 25, 1985
The regional distribution of receptors for vasoactive intestinal polypeptide (VIP) in the rat central nervous systemP Staun-Olsen, B Ottesen, S Gammeltoft, et al.
European Journal of Cancer Care|July 21, 2011
Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancerK M Robinson, K B Christensen, B Ottesen, et al.
Obesity Research|October 12, 2001
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapyM B Sørensen, A M Rosenfalck, L Højgaard, et al.
Acta Physiologica Scandinavica|October 1, 1994
Pituitary adenylate cyclase activating polypeptide induces vascular relaxation and inhibits non-vascular smooth muscle activity in the rabbit female genital tractB R Steenstrup, B Ottesen, M Jørgensen, et al.
Regulatory Peptides|December 30, 1986
Effect of vasoactive intestinal polypeptide (VIP) on steroidogenesis in womenB Ottesen, B Pedersen, J Nielsen, et al.
Annals of the New York Academy of Sciences|December 26, 1996
The effect of neuropeptides on vessel tone and cAMP productionW Yao, S P Sheikh, B Ottesen, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Urology|May 1, 1992
Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failureT C Gerstenberg, P Metz, B Ottesen, et al.
Clinical and Experimental Pharmacology & Physiology|January 1, 1990
Vasoactive intestinal polypeptide and human vaginal blood flow: comparison between transvaginal and intravenous administrationC Palle, H E Bredkjaer, B Ottesen, et al.
American Journal of Obstetrics and Gynecology|February 1, 1991
Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopauseC Palle, H E Bredkjaer, J Fahrenkrug, et al.
Endocrinology|October 1, 1984
Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyisB Ottesen, B Hansen, J Fahrenkrug, et al.
Brain Research|March 25, 1985
The regional distribution of receptors for vasoactive intestinal polypeptide (VIP) in the rat central nervous systemP Staun-Olsen, B Ottesen, S Gammeltoft, et al.
European Journal of Cancer Care|July 21, 2011
Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancerK M Robinson, K B Christensen, B Ottesen, et al.
Obesity Research|October 12, 2001
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapyM B Sørensen, A M Rosenfalck, L Højgaard, et al.
Acta Physiologica Scandinavica|October 1, 1994
Pituitary adenylate cyclase activating polypeptide induces vascular relaxation and inhibits non-vascular smooth muscle activity in the rabbit female genital tractB R Steenstrup, B Ottesen, M Jørgensen, et al.
Regulatory Peptides|December 30, 1986
Effect of vasoactive intestinal polypeptide (VIP) on steroidogenesis in womenB Ottesen, B Pedersen, J Nielsen, et al.
Annals of the New York Academy of Sciences|December 26, 1996
The effect of neuropeptides on vessel tone and cAMP productionW Yao, S P Sheikh, B Ottesen, et al.
Pageof 13